Evaluation of ICP-B794 in Patients With Advanced Solid Tumors
Clinical trial NCT07136558 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07136558
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2029-06-01
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.